William N. Malatestinic

Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study

Gil Yosipovitch, Peter Foley, Caitriona Ryan et al. · The Journal of Sexual Medicine · 2018 · 50 citations · Full text

Medicine, Dermatology, Pharmacotherapy +11

Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab

Andrew Blauvelt, Nianwen Shi, Russel Burge et al. · Journal of the American Academy of Dermatology · 2019 · 46 citations

Medicine, Dermatology, Pharmacotherapy +7

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry

Benjamin Lockshin, Angel M. Cronin, Ryan W. Harrison et al. · Dermatologic Therapy · 2021 · 45 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis

S. Al Sawah, Shonda A. Foster, Orin M. Goldblum et al. · Journal of Medical Economics · 2017 · 44 citations

Medicine, Dermatology, Pharmacoeconomics +17

Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization

April W. Armstrong, Shonda A. Foster, Brian S. Comer et al. · BMC Dermatology · 2018 · 32 citations · Full text

Pharmacy, Dermatology, Health Informatics +16